Miss Kitty. You are right about bio tech runs these days. All macro conditions are a little scary. I still think PSDV is the sleeper of the year. Great potential. Cancer drugs like EXEL, DNDN and such are tough trek anyway. I stay away in a big way. ZIOP is supposed to be the next big one and has been hit as well. Rosey was spotted on ALIM board, he hates that too, with an absolute passion. Hard to say which he hated more. In my mind he is a weak human being for not standing up to his obligations. Good luck to all longs in this painful wait.